EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mesenchymal Stem Cell–Derived Extracellular Vesicles in Acute Kidney Injury: Sourcing, Characteristics, and Prospects for Clinical Application

Thi Kim Chi Tran, Henry H. L. Wu, Long The Nguyen, Carol A. Pollock, Sonia Saad

International Journal of Nephrology · 2026-01 · 2026 (1)

DOI: 10.1155/ijne/6387996 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nephrology, online erschienen am 19.11.2026. Verfasst von Thi Kim Chi Tran und 4 weiteren Autor:innen. Die Arbeit nennt 169 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Approximately 13.3 million people each year are affected by acute kidney injury (AKI). Current treatments for AKI are mainly supportive, with no established definitive treatment. However, advances in regenerative medicine have made mesenchymal stem cell–derived extracellular vesicles (MSC‐EVs) a promising cell‐free therapy for AKI. Across preclinical models, MSC‐EVs from different tissue origins consistently alleviated AKI, primarily through paracrine signaling and by restoring mitochondrial function. Despite promising preclinical animal data, small‐scale, short‐term studies constrain MSC‐EV translation to human use. Translating MSC‐EV‐based treatments to clinical settings is still in its infancy, with no regulatory approvals. This review defines, characterizes, and classifies MSC‐EVs; describes the bio‐cargoes they carry; and examines the mechanisms by which MSC‐EVs from different origins confer renoprotection in AKI models. In doing so, we provide novel insight into functional differences not only between MSC‐EVs from conventional tissue sources but also between newly emerging sources, which recent literature has not systematically addressed or integrated. To provide a comprehensive narrative, we also summarize several limitations that impede the use of MSC‐EVs in preclinical and clinical settings and critically discuss ways to improve their feasibility for therapeutic application.

Zitieren

APA

Tran, T. K. C., Wu, H. H. L., Nguyen, L. T., Pollock, C. A., & Saad, S. (2026). Mesenchymal Stem Cell–Derived Extracellular Vesicles in Acute Kidney Injury: Sourcing, Characteristics, and Prospects for Clinical Application. International Journal of Nephrology, 2026(1). https://doi.org/10.1155/ijne/6387996

Vancouver

Tran TKC, Wu HHL, Nguyen LT, Pollock CA, Saad S. Mesenchymal Stem Cell–Derived Extracellular Vesicles in Acute Kidney Injury: Sourcing, Characteristics, and Prospects for Clinical Application. International Journal of Nephrology. 2026;2026(1). doi:10.1155/ijne/6387996

BibTeX
@article{Tran2026,
  author = {Tran, Thi Kim Chi and Wu, Henry H. L. and Nguyen, Long The and Pollock, Carol A. and Saad, Sonia},
  title = {Mesenchymal Stem Cell–Derived Extracellular Vesicles in Acute Kidney Injury: Sourcing, Characteristics, and Prospects for Clinical Application},
  journal = {International Journal of Nephrology},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/ijne/6387996}
}
Kostenlos starten →